Carregando...
Cost-effectiveness of QuantiFERON testing prior to initiation of biologic therapy in inflammatory bowel disease
BACKGROUND: Anti-TNF α drugs are known to reactivate latent tuberculosis (TB). Current guidelines recommend screening for latent TB infection (LTBI), with either tuberculin skin test (TST) or interferon gamma release assays (IGRA) such as QuantiFERON-TB Gold (QFT-G). Given the high rates of anergy t...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3889121/ https://ncbi.nlm.nih.gov/pubmed/23945184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MIB.0b013e31829f008f |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|